ClinicalTrials.gg
Drug

Terbinafine clinical trials

Also written Lamisil and MOB015B.

studies test it
46
open now
7
in phase 3
15
first study started
2002

How each study uses Terbinafine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Terbinafine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
30 Dec 1992 · LAMISIL · NDA 020192 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Terbinafine
15
Terbinafine Hydrochloride
4
Terbinafine HCl 250mg tablets
2
Terbinafine Hydrochloride Tablets 250 mg
2
Terbinafine Hydrochloride Tablets, 250 mg
2

Brand

Lamisil
8

Development codes

MOB015B
7
TDT067
1

Studies by the year they started

45 studies that test it; most in 2004 (6)

Studies that test Terbinafine, by start year
YearStudies
20024
20046
20051
20062
20071
20091
20102
20113
20121
20163
20175
20181
20191
20213
20223
20231
20241
20253
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
14
Phase 2
12
Phase 3
15
Phase 4
1
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 31 · Other 15

Moberg Pharma AB (7) · Novartis (4) · Novartis Pharmaceuticals (3) · Assiut University (3) · Teva Pharmaceuticals USA (2) · Mylan Pharmaceuticals Inc (2) · Roxane Laboratories (2) · Celtic Pharma Development Services (2)

Often tested with

Tested in the same studies.

Itraconazole (5) · Metronidazole (1) · Doxycycline (1) · Platelet rich plasma (1) · Butenafine (1) · Isotretinoin (1)

Studies

Open first, then newest update. How each study uses Terbinafine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 46

See all 46 studies that test Terbinafine →

Given beside what is tested · 1 — Terbinafine is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with Terbinafine

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call Terbinafine · ClinicalTrials.gg INT006691

  • MeSH (NLM) D000077291TerbinafineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) G7RIW8S0XPTERBINAFINEConfirmed FDA, NLM, Wikidata
  • RxNorm 37801Confirmed FDA, Wikidata
  • Wikidata Q415259terbinafineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C48019TerbinafineOne source FDA
  • DrugBank DB00857One source Wikidata

Also registered as terbinafine hydrochloride (UNII 012C11ZU6G · RxNorm 235838) and terbinafine, (z)- (UNII S76S370M70).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.